30.1.2024 10:34:32 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Reference is made to the announcement by Aqua Bio Technology ASA on 30 January 2024 concerning, among other things, a private placement with total gross proceeds of approximately NOK 12.46 million and a contemplated subsequent offering (the “Subsequent Offering”).
Date on which the terms of the Subsequent Offering was announced:
29 January 2024
Last day including right:
30 January 2024
First day excluding right:
31 January 2024
Record date:
1 February 2024
Resolution date:
30 January 2024
Maximum number of new shares:
1,000,000
Subscription price:
NOK 5
Shall the rights be listed
No
The formal resolution related to the Subsequent Offering will be made by the board of directors at a later time, and further information will be given in due course.
This information is published in accordance with the requirements of the Continuing Obligations.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
Download announcement as PDF.pdf
